 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease |
| Jinmi Lee, Seok-Woo Hong, Eun-Jung Rhee, Won-Young Lee |
|
Diabetes Metab J. 2012;36(4):262-267. Published online August 20, 2012 DOI: https://doi.org/10.4093/dmj.2012.36.4.262 |
|
GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease Diabetes & Metabolism Journal. 2012;36(4):262  HM15211, a novel GLP-1/GIP/Glucagon triple-receptor co-agonist significantly reduces liver fat and body weight in obese subjects with non-alcoholic fatty liver disease: A Phase 1b/2a, multi-center, randomized, placebo-controlled trial Journal of Hepatology. 2020;73:S124 Treatment of non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology. 2002;17:S385-S388 Non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology. 2002;17:S186-S190 Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review Archives of Hepatitis Research. 2017;3(1):029-036 Non-alcoholic fatty liver disease Journal of Diabetes. 2012;4(3):266-280 Non-alcoholic fatty liver disease Alimentary Pharmacology & Therapeutics. 2003;17(8):977-986 Clinicopathological features of non-alcoholic fatty liver disease Hepatology Research. 2011;41(10):911-920 Treatment of non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology. 2013;28:79-80 Su1498 - A Highly Selective and Potent Farnesoid X Receptor (FXR) Agonist EDP-305 Reduces Liver Steatosis, Ballooning, and Non-Alcoholic Fatty Liver Disease Activity (NAS) in two Murine Models of Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 2018;154(6):S-1159 |
